Vitrolife AB Announces Election Committee for Annual General Meeting 2024
Vitrolife AB, a leading global provider of products and services for assisted reproduction, has announced the appointment of the election committee for its Annual General Meeting in 2024. The committee comprises esteemed individuals with extensive experience in the industry and corporate governance.
The members of the election committee include Niels Jacobsen, appointed by William Demant Invest A/S; Patrik Tigerschiöld, appointed by Bure Equity AB; Caroline Sjösten, appointed by Swedbank Robur Fonder AB; and Jón Sigurdsson, Chairman of the Board.
These appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee, as determined at the Annual General Meeting of Vitrolife AB on April 27, 2023.
The Annual General Meeting of Vitrolife AB (publ) is scheduled to take place on April 25, 2024, in Gothenburg. Shareholders who wish to have an item considered at the meeting can submit a request to the Board. Such requests should be sent to Vitrolife AB (publ), Att: Chairman of the Board, Box 9080, 400 92 Gothenburg, and must be received by the Board no later than seven weeks before the Annual General Meeting.
Vitrolife AB (publ) is committed to transparency and compliance with regulatory requirements. This disclosure is in accordance with the Swedish Securities Markets Act (2007:528).
For further information, please contact Jón Sigurdsson, Chairman of the Board, via email at email@example.com, or Patrik Tolf, CFO, at +46 31 766 90 21.
Vitrolife AB continues to demonstrate its dedication to corporate governance and shareholder engagement through the appointment of a well-qualified election committee. The company looks forward to a successful Annual General Meeting in 2024, where important matters will be discussed and decisions made to drive the future growth and success of Vitrolife AB.